Doerfler P, Schoefmann N, Stuetz A, Wolff-Winiski B (2022)
Development of a “theranostic” assay for chronic wounds and identification of compounds with so far unknown potential for treatment of chronic wounds
Oral presentation at the ÖGMBT 2022 Annual Meeting, Sept 19-22, 2022, in Vienna, Austria

Doerfler P, Schoefmann N, Cabral G, Stuetz A, Wolff-Winiski B (2024)
Identification and characterization of potential wound therapeutics based on a new personalized ex vivo wound model.
Poster at the ETRS-WHS-SKINTERM 2024 Annual Meeting, Sept. 24-27, 2024 in Amersfoort, Netherlands

Cabral G, Doerfler P, Schoefmann N, Stuetz A, Wolff-Winiski B (2023)
Development of personalized treatment for chronic wounds
Oral presentation at the ETRS 2022, Sept. 15-17, 2022, in Lyon, France

Wolff-Winiski B, Doerfler P, Schoefmann N, Cabral G,  Stuetz A (2024)
Patient-specific assays to identify and characterize new drugs for chronic wound therapy.
Oral presentation at the EUSAAT Congress 2024, September 18-20, 2024, Linz, Austria
ALTEX Proceedings 12(2), 2024, EUSAAT, p.107.

Cabral G, Doerfler P, Schoefmann N, Stuetz A, Wolff-Winiski B (2024)
Transcriptional changes in fibroblasts exposed to non-healing wound exudates reveal a role for the unfolded protein response in the pathology of chronic wounds.
Oral presentation at the European Wound Management Association (EWMA) Meeting, May 01-03, 2024, London, UK

Schoefmann N, Schwarz A, Kotzbeck P, Wolff-Winiski B (2023)
Effect of chronic wound exudates on human adipocytes.
Poster at the European Wound Management Association (EWMA) meeting, May. 3 - 5, 2023 in Milan, Italy

Cabral G, Doerfler P, Schoefmann N, Stuetz A, Wolff-Winiski B (2023)
The early transcriptional response of fibroblasts to non-healing wound exudates reveals roles for inflammation and unfolded protein response in the pathology of chronic wounds.
Poster at the 5^th Inflammatory Skin Disease Summit (ISDS), Nov. 15-18, 2023, Vienna, Austria

Wolff-Winiski B, Doerfler P, Schoefmann N, Cabral G, Stuetz A. (2022)
Development of an assay platform for personalized treatment of chronic wounds.
51st Annual ESDR Meeting, Sept. 28 – Oct. 1 2022, Amsterdam, The Netherlands
J Invest Dermatol 142 (12) Suppl S286 Abstr. No 602

Schoefmann N, Doerfler P, Cabral G, Stuetz A, Wolff-Winiski B (2022)
Characterization of poly(ADP-ribose) polymerase (PARP) inhibitors as potential new drugs for chronic wound therapy.
EWMA-Journées Cicatrisations Meeting, May 23-25, 2022, Paris, France
J Wound Management 23 (1) S62 Abstr. No EP194

Cabral G, Doerfler P, Schoefmann N, Stuetz A, Wolff-Winiski B (2021)
Exposure of human dermal fibroblasts to chronic wound exudates triggers pro-inflammatory and anti-proliferative transcriptional changes.
Poster at the European Wound Management Association (EWMA), 26-27 October, 2021